Mobility Tape - with Heat
Natural health product licensed in Canada
- Other names
- Mobility Tape, Mobility Tape with Heat
- Licence holder
- Mobility Therapeutic Tape (2017) Ltd.
- NPN or DIN-HM
- 80100768
- Status
- Active licence
- Licence date
- 25 May 2020
- Revision date
- 14 April 2022
- Form
- Timbre transdermique
- Route of administration
- Topique
- Application type
- Officinale
Oral dose analysis does not apply without an established exclusively oral route.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source |
|---|---|
| l-Menthol Source : l-Menthol | 7.7 % |
Non-medicinal ingredients
Émulsion de copolymère d'acrylate de méthyle et d'acrylate de 2-éthylhexyle, Acrylate d'éthylhexyle, Acétate d'éthyle, Coton, Polyuréthane-1, Polymère croisé de HDI/triméthylol hexyllactone, Dioxyde de silicium
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 18 years | Not specified | Not specified |
Uses authorised in Canada
Temporarily relieves aches and pains of muscles and joints associated with one or more of the following: Simple backache, lumbago, strains and sprains (involving muscles, tendons, and/or ligaments), and arthritis.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
Call a Poison Control Center immediately if overdose or accidental ingestion occurs. Consult a health care practitioner/health care provider/health care professional/doctor/physician prior to use if you are pregnant or breastfeeding. Keep out of the reach of children. Stop use and consult a health care practitioner/health care provider/health care professional/ doctor/physician if symptoms worsen, or re-occur within a few days.
- Effets indésirables connus
If you experience pain, swelling or blistering, stop use and get medical help right away. Stop use and get medical help right away if you experience pain, swelling or blistering.
Source
Official Health Canada record, licence 80100768
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2022. Photograph the packaging to check whether it has changed. Photograph the packaging